Improving Access to Cures Through Innovation
Tuesday, August 18, 2020 - 08:00am
Patients deserve affordable access to the best healthcare possible. That’s why Pfizer invests in research and development: to produce groundbreaking treatments, like the COVID-19 vaccine, that improve people’s lives. It’s this investment in innovation that enables our scientists to make dramatic strides in healthcare. Their work advances life-changing therapies for the millions of patients we serve.
To help even more patients access the medications they depend on, we need smart public policies that support both access and innovation. Americans deserve healthcare solutions that:
- Increase affordable access to breakthrough treatments.
- Support the development of more treatment options by increasing access to biosimilars. Biosimilars are FDA approved, and often offer a lower-cost alternative to biologic therapies that treat challenging diseases like cancer, diabetes, and rheumatoid arthritis. Biosimilars give patients a safe and often lower cost option to their originator biologics.
- Deliver meaningful healthcare savings directly to patients through rebate reform that cuts out the middlemen. In the current broken rebate system, insurers and pharmacy benefit managers negotiate substantial rebates with pharmaceutical companies to lower the price of medicines. Instead of passing the rebate on to patients, middlemen are siphoning off these savings.
- Promote market competition and protect innovation by rejecting foreign price controls on prescription drugs. Price controls would base the price of medicines sold in the U.S. on the policies of foreign governments — and could alter how doctors and patients access drugs. This dangerous policy could have long-term harmful effects on patients by undercutting innovation and limiting access to life-saving medicines.
Help protect your constituents’ healthcare by supporting solutions that protect innovation and increase access to life-saving treatments!
Recent Updates and Statements
05.01.2024 Albert Bourla Cancer Covid-19 Diversity & Inclusion Leadership Vaccines April Social Media Round-Up—Black Maternal Health, World Immunization, and Long Covid 04.30.2024 Cancer Covid-19 Leadership Technology Pfizer Goes Live in SXSW’s Podcast Lounge 04.09.2024 Albert Bourla Cancer Diversity & Inclusion Leadership March Social Media Round-Up—Annual Review, International Women’s Day, and a School of Science Celebration 04.05.2024 Breast Cancer Cancer Research Working to “Outdo” Cancer: A Multi-Modality Approach to Accelerating the Next Generation of Cancer Breakthroughs 03.27.2024 Health Equity Partnerships Rare Diseases Pfizer Teams With Black British Choir to Bring Awareness to Sickle Cell, Rare Diseases
Off